Cosmetic composition containing a neuropeptide Y receptor antagonist
AssigneeSanofi
InventorsElisabeth Blanc-Ferras, Fran.cedilla.oise Bono Colombie, Bernard Breda, Jean Courregelongue, Catherine Ducasse, Remy Mounier, Paul Raymond, Michel Sabadie, Claudine Serradeil-Le-Gal, Vilain Pol, Jean-Marie Pereillo
Life of this patent
Estimating the term…
Abstract
This invention relates to a cosmetic composition containing at least one NPY-antagonist component mixed with an excipient for cosmetic preparations.
Claims16
A slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient, wherein the neuropeptide Y antagonist is a fermentation product of the strain Streptomyces sp SEBR 2794 as well as productive mutants thereof.
A slimming composition for topical application comprising a neuropeptide Y antagonist and an a2 antagonist in combination with cosmetically acceptable excipient, wherein the a2 antagonist is a fermentation product of the strain Bacillus licheniformis SEBR 2464 as well as productive mutants thereof.
A slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient, wherein the neuropeptide Y antagonist is a fermentation product of the strain Streptomyces sp SEBR 2794 and the a2 antagonist is a fermentation product of the strain Bacillus licheniformis SEBR 2464.
A slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient, additionally containing caffeine and extract of Ginkgo biloba.
A slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient, additionally containing a collagen synthesis stimulator, a collagenase or elastase inhibitor, or a vasoprotector.
A method of achieving a slimming effect, which process comprises topically applying to selected parts of the body a slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient.
A method of controlling lipolysis/lipogenesis in the skin which comprises applying to the skin a slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient.
A method of attenuating the fatty, "orange peel" appearance of the skin which comprises applying to the skin a A slimming composition for topical application comprising a neuropeptide Y antagonist and an .alpha.2 antagonist in combination with cosmetically acceptable excipient.
Dependencies are inferred from the claim text.